-+ 0.00%
-+ 0.00%
-+ 0.00%

TEVA AND SAMSUNG BIOEPIS ANNOUNCE AGREEMENT TO COMMERCIALIZE TWO FDA-APPROVED BIOSIMILARS IN THE U.S.

Reuters·11/03/2026 10:02:16